Skip to main content

Table 4 Observed (O) and Expected (E) numbers of people with an admission for DVT or PE

From: Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study

 

Dataset (years)

Immune-mediated disease (ICD code3)

ORLS1 (1963 to 1998)

ORLS2 (1999 to 2008)

England (1999 to 2008)

 

O

E

O

E

O

E

Addison's disease (255.4)

13

8.7

12

4.1

205

95.9

Ankylosing spondylitis (720)

18

13.4

10

8.5

373

194.7

Autoimmune haemolytic anaemia (283)

16

5.7

17

4.7

353

93.4

Chronic active hepatitis (571.4)

15

6.7

6

1.5

93

45.7

Coeliac disease (579.0)

27

20.0

24

17.8

474

392.0

Dermatomyositis, polymyositis (710.3,710.4)

11

5.6

7

2.4

167

55.2

Diabetes mellitus under 30 (250)

23

11.2

18

6.7

224

96.9

Goodpasture's syndrome (466.2)

2

0.9

4

0.6

24

8.6

Hashimoto's thyroiditis (245)

8

9.0

3

3.3

100

70.9

Idiopathic thrombocytopenia purpura (287.3)

9

4.4

21

13.4

465

225.0

Multiple sclerosis (340)

106

48.2

88

36.6

1509

728.8

Myasthenia gravis (358)

13

6.4

13

5.6

282

125.9

Myxoedema (244)

202

139.8

431

342.2

11104

9284.7

Pemphigus, pemphigoid (694.4,694.5)

38

14.2

23

7.1

375

170.8

Pernicious anaemia (281)

120

100.5

30

21.0

1012

754.2

Polyarteritis nodosa (446)

18

6.3

3

0.7

73

20.7

Primary biliary cirrhosis (571.6)

7

5.4

11

4.0

150

101.2

Psoriasis (696.0,696.1,696.8,696.9)

99

61.7

53

32.8

1318

812.5

Rheumatoid arthritis (714)

450

322.1

281

192.9

6825

4352.5

Scleroderma (710.1)

9

4.2

9

5.9

244

124.8

Sjogren's syndrome (710.2)

10

3.5

13

6.8

305

152.2

Systemic lupus erythematosus (710.0)

26

7.2

35

7.8

636

174.8

Thyrotoxicosis (242)

134

117.8

83

54.7

1429

1081.7